Tag: CGuard EPS

January 24, 2019

InspireMD Announces Presentation of Interim Data from Investigator-Initiated Study

InspireMD (NYSE:NSPR), developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of...
January 14, 2019

InspireMD Announces the Distribution of CGuard Embolic Prevention System in South Africa

InspireMD (NYSE:NSPR), developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of...
September 21, 2017

InspireMD Announces Distribution Agreement in Portugal

InspireMD announced it has signed an agreement with Medicinália Cormédica MC Medical Lda, a medical distributor in Portugal, to distribute...
August 3, 2017

InspireMD's CGuard System Featured at Cardiology Congress

InspireMD announced the endovascular interventional procedure which features the CGuard EPS was recorded and presented at this year's SOLACI CACI...
June 5, 2017

InspireMD Signs Distribution Agreement with Arteriae

InspireMD signed an agreement with Arteriae, a medical distributor leader in Poland, to distribute CGuard Embolic Prevention System.
May 31, 2017

InspireMD's CGuard EPS Treats Patients in Hong Kong

InspireMD announced the positive treatment of two patients in Hong Kong using CGuard EPS.
May 17, 2017

InspireMD Reveals IRON-GUARD Trial Findings

InspireMD shared the publication of an IRON-GUARD clinical registry in a peer-reviewed journal.